[ad_1]
Hyderabad: The 20th edition of BioAsia, Asia’s largest convention for life sciences and healthcare, witnessed its second day of ambitious deliberations among some of the world’s largest healthcare industry stakeholders. The event witnessed high-profile deliberations among governments, businesses, veteran healthcare leaders, academia and start-ups to discuss global healthcare challenges. Day two of BioAsia witnessed strategic discussions on the exponential impact that the fusion of technology and life sciences can create in providing an opportunity for every challenge in the global industry.
Day two of BioAsia 2023 boasted 5 panel discussions and a thunderous fireside chat between Dr. Sumbul Desai, VP Health, Apple, USA and Dr. Sangita Reddy, Joint Managing Director, Apollo Hospitals, India. The panels deliberated on the key pillars that underpin the global growth of the life sciences industry. The first panel on ‘Data, Analytics and Technology to Transform Medicines R&D: Redefining Innovation’, delved into the benefits of using data and technology analytics in the R&D process and the opportunities which this introduces to India. The next panel on “India for India and India for the World: Where is Quality?” A third panel on “Medical Technology Penetration: What’s the Way Forward?” witness leaders discussing avenues that will best enable India to continue to strengthen the medical device ecosystem by leveraging India’s inherent IT strength. Experts commented on how this robust IT sector will contribute to the drug registry and address the problem of counterfeit drugs, in a subsequent panel on “Integrated Healthcare: The Future of the Care Delivery Model.” Yet another critical panel on “Transforming the Global Supply Chain” deliberated on sustainability enablement practices related to manufacturing and supply chain and the adoption of ESG criteria as a culture.
Mr. KT Ramarao, Minister of Industry & Trade and IT, Government of Telangana presided over the farewell ceremony, where he praised the huge impact created by BioAsia. He said, “BioAsia, one of the largest life science events in Asia, witnessed its largest edition this year, in terms of the impact it has created. More than 2,000 delegates, 175 exhibitors and start-ups, representation of 50 countries and more than 2,000 B2B meetings were held in the last 2 days. What I’m excited about is the way forward and the possibilities for how technology can serve as a force multiplier to help the life sciences industry innovate and scale in terms of ambition. I am excited how the most precious resource we have at our disposal, human capital, young India can start working on world-class innovations.”
“I am excited about the opportunities India presents in terms of scale, in terms of manufacturing medical devices, pharmaceuticals and all kinds of life science products. I am a firm believer in the mantra of the 3 I’s – Innovation, Infrastructure and Inclusive Growth – these 3Is can make the 4th I – India, a true hotbed of talented first world countries in the times to come,” he added.
Day 2 of BioAsia concluded with a stunning startup showcase comprised of 76 brilliant attendees from national and international geographies. 5 start-ups, including the most innovative and futuristic products and services, were chosen by a brilliant jury.
1. Exobot Dynamics Pvt Ltd – Exobot develops bionic limbs, exoskeletons and assistive devices to improve the health and performance of the disabled, sick and able-bodied.
2. Lambdagen Therapeutics – Lambdagen Therapeutics Singapore in collaboration with University of MD Anderson Cancer Center, USA aims to develop a myeloid brain tumor cell-based cancer vaccine customized with LambdaGen’s proprietary non-viral genome engineering technology pipelines .
3. Pratibha Healthkon – a Telangana-based healthcare and medtech start-up that has positioned itself as a leading solutions provider and open innovation partner for companies in the primary healthcare sector that provide the workflow for population screening management and ‘accompanying the individual across the continuum of care from within the community to PHCs.
4. Ramja Genosensor – Ramja is the world’s first paper-based device that can detect any infection and antimicrobial resistance in just 90 minutes.
5. SatyaRX Pharma Innovations Pvt Ltd – a drug discovery company focused on the discovery and development of new cancer drugs. The company is focused on the global markets for its anticancer drugs and has developed specific expertise in the DNA damage response pathway.
Mr. Jayesh Ranjan, IAS, Principal Secretary, Industries & Commerce Dept, Govt of Telangana added, “Each year, BioAsia drives global renewal of joint efforts to develop healthcare innovation at scale. 2023, the year in which we will physically host BioAsia again, marks a fundamental step forward in significantly strengthening collaboration and understanding between industry, academia and governments. The Telangana government is a proud host of this monumental platform which I am sure will spur the initiation of revolutionary innovations and alliances.”
Commenting on BioAsia’s ongoing sessions, Shakthi Nagappan, CEO, BioAsia and Director, Telangana Life Sciences, Government of Telangana said, “We are delighted to once again host BioAsia in person after 2 years of virtualization. Nothing will replace the power of knowledge sharing and in-person collaborations that occur every year at BioAsia. In the last 2 days of the global bio-business conference we have witnessed significant and beneficial deliberations. Conference panels are designed to address topics of global health relevance. We strongly believe that these discussions will open the door to further discoveries, partnerships and business alliances among innovators from around the world as they venture towards Healthcare for All.”
The Minister of IT and Industry @KTBRS addressed the farewell ceremony of #BioAsia2023, the largest and most successful BioAsia ever: more than 2015 delegates attended, over 50 countries represented and in the last 2 days held more than 2000 B2B meetings. pic.twitter.com/brthQXPwH5
– Minister of IT, Industries, MA & UD, Telangana (@MinisterKTR) February 25, 2023
|
Sources 2/ https://english.sakshi.com/news/telangana/day-2-bioasia-international-commitment-life-sciences-industry-elevates-importance The mention sources can contact us to remove/changing this article |
[ad_2]